Transcriptomics-based prediction of recurrence-free survival in prostate cancer following prostatectomy

dc.check.date2026-09-30
dc.contributor.advisorWolsztynski, Eric
dc.contributor.advisorCronin, Michael
dc.contributor.advisorexternalMoghaddam, Shirin
dc.contributor.authorO'Donnell, Autumn
dc.contributor.funderHigher Education Authorityen
dc.contributor.funderScience Foundation Irelanden
dc.date.accessioned2025-05-20T10:28:01Z
dc.date.available2025-05-20T10:28:01Z
dc.date.issued2024
dc.date.submitted2024
dc.description.abstractThis thesis investigates the application of machine learning (ML) methods for survival analysis, to the prediction of biochemical recurrence (BCR) in prostate cancer patients following radical prostatectomy, using mRNA expression data. While conventional survival analysis methods remain commonplace in clinical applications, they are unfeasible with high-dimensional data such as mRNA assays and rely on assumptions that may not fully capture the complexity of cancer recurrence. This research explores the potential of ML techniques to overcome these limitations, offering more accurate and personalised predictions for prostate cancer outcomes. A systematic review of the current literature on the use of ML for survival analysis in cancer was carried out to identify key methodologies and their performance compared to traditional statistical approaches. This review highlights a need for improved reporting and standardisation in the field. The findings informed the selection of ML models for further study, including random survival forests (RSF), LASSO Cox, and boosted Cox models. This research’s first experimental phase focuses on post-operative BCR prediction, where mRNA data from tumour tissue was integrated with clinical variables with the aim of improving performance. Results demonstrated that ML models incorporating mRNA expression outperformed those with clinical variables alone and could also improve on traditional Cox proportional hazards (CPH) models. The second phase extends the analysis to pre-operative settings, exploring the potential feasibility of using mRNA data to predict BCR before surgery. This pre-operative model also showed significant promise, suggesting the potential for early intervention strategies that could better inform treatment decisions. The study contributes to the growing field of precision oncology, offering insights into how genetic information and ML can be leveraged to improve clinical decision-making in prostate cancer.en
dc.description.statusNot peer revieweden
dc.description.versionAccepted Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationO'Donnell, A. 2024. Transcriptomics-based prediction of recurrence-free survival in prostate cancer following prostatectomy. PhD Thesis, University College Cork.
dc.identifier.endpage166
dc.identifier.urihttps://hdl.handle.net/10468/17534
dc.language.isoenen
dc.publisherUniversity College Corken
dc.relation.projectHuman Capital Initiative Pillar 1, 2020
dc.relation.project12/RC/2289-P2
dc.relation.projectinfo:eu-repo/grantAgreement/SFI/Maternity/Adoptive Leave Allowance/12/RC/2289-P2s9/IE/INSIGHT Phase 2/
dc.rights© 2024, Autumn O'Donnell.
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCancer
dc.subjectProstate cancer
dc.subjectStatistics
dc.subjectSurvival analysis
dc.subjectMachine learning
dc.subjectGenomics
dc.subjectmRNA
dc.subjectTranscriptomics
dc.titleTranscriptomics-based prediction of recurrence-free survival in prostate cancer following prostatectomy
dc.typeDoctoral thesisen
dc.type.qualificationlevelDoctoralen
dc.type.qualificationnamePhD - Doctor of Philosophyen
Files
Original bundle
Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
ODonnellA_PhD2024.pdf
Size:
1.91 MB
Format:
Adobe Portable Document Format
Description:
Full Text E-thesis
Loading...
Thumbnail Image
Name:
ODonnellA_PhD2024_Submission for examination form.pdf
Size:
373.31 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
5.2 KB
Format:
Item-specific license agreed upon to submission
Description: